Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
ClarkeKann Lawyers
As the Australian population ages, demand for special accommodation, services and care continues to increase rapidly.
Corrs Chambers Westgarth
This decision may allow innovators to block the launch of certain generics, even without a claim of patent infringement.
King & Wood Mallesons
This article reviews highlights of the recent amendments and discusses the provisions of the Second Revised Amendment.
King & Wood Mallesons
This series of regulatory actions demonstrate efforts to strengthen the administration of medical devices and equipment.
Ropes & Gray LLP
The CFDA expects all device companies to comply with the New GMP and GSP rules as long as they intend to sell the products in China.
Ropes & Gray LLP
On November 21, 2014, China Food and Drug Administration ("CFDA") released a Draft Guidance on Multi-Regional Clinical Trials (Provisional) ("Guidance") for public comments through December 21.
King & Wood Mallesons
Reflections focus on the topics of: response time; response attitude; internal PR teams and official press conferences.
Ropes & Gray LLP
The Center for Drug Evaluation of the China Food and Drug Administration published a long-awaited guidance document for companies seeking to develop biosimilars.
Broad & Bright
People are growing increasingly conscientious about their health, and the pharmaceutical industry has become an important part of the national economy.
Ropes & Gray LLP
China’s health authority, the National Health and Family Planning Commission, released the Administrative Measures for the Clinical Study Projects of Medical Institutions.
Foley & Lardner
This post is the second in Foley’s blogs on China telemedicine and the first in the blog series, "Realizing the Potential of Telemedicine in China," meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market. We hope to expand the series to include additional issues.
Foley & Lardner
Telemedicine providers and vendors doing business in China, whether based in China, the United States, or elsewhere, received new guidance on the use of telemedicine.
Jones Day
Two individuals will be prosecuted shortly in Shanghai for conducting illegal investigations and purchase of personal information in China.
Jones Day
China continues to struggle in its efforts to improve food safety regulation and oversight, in the wake of a succession of food safety problems.
Ropes & Gray LLP
The amended Regulation for the Supervision and Administration of Medical Devices (the "Regulation," also known as the State Council Order No. 650), which came into force on June 1, 2014, set the new framework for China’s device regulatory regime.
King & Wood Mallesons
This newsletter discusses the differences between the Amendment and the Revised Amendment, and the underlying rationale.
DaHui Lawyers
A number of recent commercial bribery cases concerning multinational pharmaceutical companies have drawn extensive attention.
Eiger
This article outlines the implications of the new Free Trade Agreement between China and Switzerland in relation to the trade in medical devices.
King & Wood Mallesons
The China FDA has recently promulgated the Provisions on the Food and Drug Administrative Penalty Procedure.
King & Wood Mallesons
The Revised Regulations will come into effective on 1 June 2014, presenting some major changes.
Most Popular Recent Articles
Lall & Sethi Advocates
The story continues……… those who have been reading our past newsletters will understand that in the patent landscape our focus has been pharmaceuticals
Singh & Associates
Indian Pharmaceutical Industry is at present, at its most progressive era where it has witnessed a robust growth over the past few years.
Vaish Associates Advocates
The Indian Medical Device industry has shown remarkable variation in its synthesis of demand and supply.
LexOrbis
Close on the heels of the US President's historic Republic day visit to India, Gilead, a US based Biopharmaceutical Company, was successful in securing some relief from the Delhi High Court ..
Singh & Associates
The Indian pharmaceutical industry is emerging as one of the most prospective markets in the global strata in terms of its potential.
PSA Legal Counsellors
The Union Ministry of Health and Family Welfare had released the draft Drugs and Cosmetics Bill, 2015 to amend the Drugs & Cosmetics Act, 1940.
ClarkeKann Lawyers
As the Australian population ages, demand for special accommodation, services and care continues to increase rapidly.
Singh & Associates
Hon'ble Apex Court has recently awarded a historic verdict having a major impact on medical negligence and standard of medical care in India.
Watkins Tapsell
An Advance Care Directive sets out a person's specific wishes regarding medical treatment if they become incapacitated.
LexOrbis
In India, access to health care facilities is still limited to a very small percentage of population owing mostly to unavailability of affordable drugs and treatment.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter